EVIO, Inc. Announces Partnership with Rare Earth Genomics Texas, LLC
January 04, 2022 at 11:49 am EST
Share
EVIO, Inc. announced that the company is engaging in a strategic partnership with Rare Earth Genomics Texas, LLC ("REG"). REG has been testing its hemp products with EVIO Inc. ("EVIO") since the company launched its hemp business in 2020. REG and EVIO will deepen their relationship by collaborating on a range of research and development projects that focus on optimizing hemp strains, including: Evaluation of unique terpenes and terpenoids; Quantification of major and minor cannabinoids; Optimization of screening methods for breeding populations; Development of testing protocols for novel phenotypes; Assessment of potential for soil remediation; Initiation of nutritional analyses of hemp and hemp seed feed and food products.
EVIO will provide support and training to REG in pursuit of their goal to be a premier industrial hemp entity.
EVIO, Inc. is a diversified holding company. The Company provides analytical testing services to the agricultural and pharmaceutical industries, primarily for cannabis, hemp, and related products. The Company offers residential and commercial construction services. The Company also offers research and development and consulting services for participants in the cannabis and hemp industries. The Company tests products to verify the regulatory requirements for sale. Its subsidiaries include Smith Scientific Industries, LLC; Greenhaus Analytical Labs, LLC; Viridis Analytics, LLC; EVIO Labs OR, Inc.; C3 Labs, LLC; EVIO Labs Humboldt, LLC and Keystone Labs, Inc.